Novan Inc

NASDAQ:NOVN  
7.23
-0.15 (-2.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)136.02M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.77 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$7.53
50-Day MA$8.47
200-Day MA$11.50
See more pivots

Novan Inc Stock, NASDAQ:NOVN

4020 Stirrup Creek Drive, Suite 110, Morrisville, North Carolina 27703
United States of America
Phone: +1.919.485.8080
Number of Employees: 23

Description

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxideâ??s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.